Open Access
| Issue |
BIO Web Conf.
Volume 157, 2025
The 5th Sustainability and Resilience of Coastal Management (SRCM 2024)
|
|
|---|---|---|
| Article Number | 05010 | |
| Number of page(s) | 7 | |
| Section | Environmental Monitoring and Sustainability | |
| DOI | https://doi.org/10.1051/bioconf/202515705010 | |
| Published online | 05 February 2025 | |
- Sung H, Ferlay J, Siegel R L, Laversanne M, Soerjomataram I, Jemal A and Bray F 2021 Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 71 pp 209-49 [CrossRef] [PubMed] [Google Scholar]
- Ibrahim S, Putra A, Amalina N D and Nasution I P A 2022 Heat shock protein-70 expression in CSCs tumor-associated macrophages induced by Typhonium flagelliforme tuber extract Journal of Applied Pharmaceutical Science 12 pp 146-52 [CrossRef] [Google Scholar]
- Yadav A K and Desai N S 2019 Cancer stem cells: acquisition, characteristics, therapeutic implications, targeting strategies and future prospects Stem Cell Rev Rep. 15 pp 331-55 [CrossRef] [Google Scholar]
- Hermansyah D, Putra A, Munir D, Lelo A, Amalina N D and Alif I 2021 Synergistic effect of Curcuma longa extract in combination with Phyllanthus niruri extract in regulating annexin A2, epidermal growth factor receptor, matrix metalloproteinases, and pyruvate kinase M1/2 signaling pathway on breast cancer stem cell Open Access Maced J Med Sci. 9 pp 271–85 [CrossRef] [Google Scholar]
- Alanazi I O and Khan Z 2016 Understanding EGFR signaling in breast cancer and breast cancer stem cells: overexpression and therapeutic implications. Asian Pac J Cancer Prev. 17 pp 445-53 [CrossRef] [PubMed] [Google Scholar]
- Zhao L, Qiu T, Jiang D, Xu H, Zou L, Yang Q, Chen C and Jiao B 2020 SGCE promotes breast cancer stem cells by stabilizing EGFR Advanced Science 7 pp 1-17 [Google Scholar]
- Flynn J F Wong C and Wu J M 2009 Anti-EGFR therapy: mechanism and advances in clinical efficacy in breast cancer J Oncol. pp 1-16 [Google Scholar]
- Sritharan S and Sivalingam N 2021 A comprehensive review on time-tested anticancer drug doxorubicin Life Sciences 278 pp 1-10 [Google Scholar]
- Varela-López A, Battino M, Navarro-Horta M D, Giampieri F, Forbes-Hernández T Y, Romero-Márquez J M, Collado R, Quiles J L 2019 An update on the mechanisms related to cell death and toxicity of doxorubicin and the protective role of nutrients Food and Chemical Toxicology 134 pp 1-19 [Google Scholar]
- Shady N H, El-Hossary E M, Fouad M A, Gulder T A M, Kamel M S and Abdelmohsen U R 2017 Bioactive natural products of marine sponges from the genus Hyrtios Molecules 22 pp 1-21 [Google Scholar]
- Wati F A, Santoso M, Moussa Z, Fatmawati S, Fadlan A and Judeh Z M A 2021 Chemistry of trisindolines: natural occurrence, synthesis and bioactivity RSC Advances 11 pp 25381-421 [CrossRef] [PubMed] [Google Scholar]
- Kobayashi M, Aoki S, Gato K, Matsunami K, Kurosu M and Kitagawa I 1994 Marine Naural Products. XXXIV.1) trisindoline, a new antibiotic indole trimer, produced by a bacterium of Vibrio sp. Separated from the marine sponge Hyrtios altum Chem. Pharm. Bull. 42 pp 2449-51 [CrossRef] [PubMed] [Google Scholar]
- Nurhayati A P D, Rihandoko A, Fadlan A, Ghaissani S S, Jadid N and Setiawan E 2022 Anti-cancer potency by induced apoptosis by molecular docking P53, caspase, cyclin D1, cytotoxicity analysis and phagocytosis activity of trisindoline 1, 3 and 4. Saudi Pharmaceutical Journal, in press [Google Scholar]
- Ghaissani S S 2022 Study of trisindoline 1 compound exposure in P53 and P53R2 gene expression of cancer stem cell (CSC) Master thesis Institut Teknologi Sepuluh Nopember, Biology Department [Google Scholar]
- Wati F A (2021) Development of nitrogen heterocyclic compunds as antituberculosis and anticancer. Doctoral thesis Institut Teknologi Sepuluh Nopember, Chemistry Department [Google Scholar]
- Al-Anazi M, Khairuddean M, Al-Najjar B O, Alidmat M M, Kamal N N S N M and Muhamad M 2022 Synthesis, anticancer activity and docking studies of pyrazoline and pyrimidine derivates as potential epidermal growth factor receptor (EGFR) inhibitors Arabian Journal of Chemistry 15 pp 1-10 [Google Scholar]
- Freire E 2008 Do enthalpy and entropy distinguish first in class from best in class? Drug Discov Today 13 pp 869–74 [CrossRef] [PubMed] [Google Scholar]
- Pantsar T and Poso A 2018 Binding affinity via docking: fact and fiction Molecules 23 pp 1-11 [Google Scholar]
- Kastritis P L and Bonvin A M J J 2013 On the binding affinity of macromolecular interactions: daring to ask why proteins interact J R Soc Interface 10 pp 1-27 [Google Scholar]
- Santos K B, Guedes I A, Karl A L M and Dardenne L E 2020 Highly flexible ligand docking: benchmarking of the DockThor program on the LEADS-PEP protein-peptide data set Journal of Chemical Information and Modeling 60 pp 667-83 [CrossRef] [PubMed] [Google Scholar]
- Ciardiello F and Tortora G 2008 EGFR antagonists in cancer treatment New England Journal of Medicine 358 pp 1160-74 [CrossRef] [PubMed] [Google Scholar]
- Calderon O H, Pérez A F Y, Saumeth J Q, Armas J P R, Pacheco M P, Sánchez J M O, Macedo E C C, Acevedo J L A, Salvador L F, Rojas G P and Ayme V A 2020 Carvacrol: an in silico approach of a candidate drug on HER2, PI3Kα, mTOR, hER-α, PR and EGFR receptors in the breast cancer Evidence-Based Complementary and Alternative Medicine 8830665 pp 1-12 [Google Scholar]
- Wu MY, Dai DQ and Yan H 2012 PRL-Dock: protein-ligand docking based on hydrogen bond matching and probabilistic relaxation labeling Proteins: Structure, Function, and Bioinformatics 80 pp 2137-53 [CrossRef] [PubMed] [Google Scholar]
- Pace C N, Fu H, Fryar K L, Landua J, Trevino S R, Schell D, Thurlkill R L, Imura S, Scholtz J M, Gajiwala K, Sevcik J, Urbanikova L, Myers J K, Takano K, Hebert E J, Shirley B A and Grimsley G R 2014 Contribution of hydrogen bonds to protein stability Protein Sci. 23 pp 652-61 [CrossRef] [PubMed] [Google Scholar]
- Liao Q H, Gao Q Z, Wei J and Chou K C 2011 Docking and molecular dynamics study on the inhibitory activity of novel inhibitors on epidermal growth factor receptor (EGFR) Medicinal Chemistry 7 pp 24-31 [CrossRef] [Google Scholar]
- Ono M and Kuwano M 2006 Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs Clin Cancer Res 12 pp 7242-51 [CrossRef] [PubMed] [Google Scholar]
- Masuda H, Zhang D, Bartholomeusz C, Doihara H, Hortobagyi G N and Ueno N T 2012 Role of epidermal growth factor receptor in breast cancer Breast Cancer Res Treat. 136 pp 1-21 [Google Scholar]
- Paramanantham A, Jung E J, Kim H J, Jeong B K, Jung J M, Kim G S, Chan H S and Lee W S 2021 Doxorubicin-resistant TNBC cells exhibit rapid growth with cancer stem cell-like properties and EMT phenotype, which can be transferred to parental cells through autocrine signaling Int. J. Mol. Sci. 22 pp 1-14 [Google Scholar]
- Abhold E L, Kiang A, Rahimy E, Kuo S Z, Rodriguez J W, Lopez J P, Blair K J, Yu M A, Haas M, Brumund K T, Altuna X, Patel A, Weisman R A and Ongkeko W M 2012 EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells PLoS ONE 7 pp 1-8 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.